Scopus BioPharma Inc. (SCPS)
0.00
null (null%)
At close: Jan 14, 2025, 8:00 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY22 | FY21 | FY20 | FY19 | FY18 |
| Net Income | -11.71M | -26.95M | -10.86M | -2.69M | -685.96K |
| Depreciation & Amortization | 1.73K | 1.50K | 1.44K | 664.00 | n/a |
| Stock-Based Compensation | 351.72K | 669.60K | 290.41K | 213.65K | 69.64K |
| Other Working Capital | -3.00B | -2.94B | -35.24K | n/a | n/a |
| Other Non-Cash Items | n/a | 13.47M | 6.92M | 89.15K | n/a |
| Deferred Income Tax | n/a | -1.46M | n/a | n/a | n/a |
| Change in Working Capital | 3.23M | 2.84M | 1.15M | 355.23K | -131.00K |
| Operating Cash Flow | -8.13M | -11.42M | -2.53M | -2.12M | -747.32K |
| Capital Expenditures | -1.55K | -2.00K | n/a | -4.25K | n/a |
| Acquisitions | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a |
| Investing Cash Flow | -1.55K | -2.00K | n/a | -4.25K | n/a |
| Debt Repayment | n/a | -104.50K | 2.19M | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 241.94K | -2.44M | -1.11M | 407.21K | 59.15K |
| Financial Cash Flow | 241.94K | 17.56M | 4.35M | 2.18M | 597.63K |
| Net Cash Flow | -7.82M | 6.11M | 1.80M | 35.09K | -156.56K |
| Free Cash Flow | -8.13M | -11.43M | -2.53M | -2.12M | -747.32K |